Wednesday, October 23, 2024
HomeTagsBiotechnology

Biotechnology

Biocytogen/Eucure Biopharma Announce the Completion of First Patient Dosing for Phase II Clinical Trial of YH003 in Australia

Eucure Biopharma, a wholly owned subsidiary of Biocytogen, announced the first patient dosing for a phase II clinical trial of YH003 (anti-CD40 monoclonal antibody,...

GenScript ProBio Opens China’s Largest Commercial GMP Plasmid Manufacturing Facility

GenScript ProBio announced today the opening of China's largest commercial GMP plasmid manufacturing facility during a ceremony at the site in Zhenjiang, Jiangsu Province....

Bostik Launches a new range of disposable hygiene Adhesive Products With Bio-based Renewable Content

As part of Bostik's drive towards the creation of more sustainable solutions across the value chain, the disposable hygiene Global Business Unit has developed...

Psilera Confirms PSIL-002, A New DMT Derivative, is Well-Tolerated and Non-Hallucinogenic from In Vivo Behavioral Studies

Psilera Inc. (“Psilera”), a Florida-based biotechnology company developing non-hallucinogenic derivatives of psychedelic compounds and outpatient delivery methods for the treatment of anxiety, substance abuse,...

Actemra/RoActemra approved by the European Commission to treat patients with severe COVID-19

Roche Announced that the European Commission has extended the marketing authorisation for Actemra®/RoActemra® (tocilizumab) to include the treatment of COVID-19 in adults who are...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics